Cargando…
A model system for antiviral siRNA therapeutics using exosome-based delivery
Emerging viral diseases, such as Ebola, SARS, MERS, and the pathogen causing COVID-19, SARS-CoV-2, present a challenge for the development of therapeutics because of strict biosafety handling procedures and rapid mutation of their genomes. To facilitate the development of an adaptable and testable t...
Autores principales: | Wallen, Margaret, Aqil, Farrukh, Kandimalla, Raghuram, Jeyabalan, Jeyaprakash, Auwardt, Supipi, Tyagi, Neha, Schultz, David J., Spencer, Wendy, Gupta, Ramesh C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384066/ https://www.ncbi.nlm.nih.gov/pubmed/35992044 http://dx.doi.org/10.1016/j.omtn.2022.08.011 |
Ejemplares similares
-
A model system for antiviral siRNA therapeutics using exosome-based delivery
por: Wallen, Margaret, et al.
Publicado: (2022) -
Targeted Oral Delivery of Paclitaxel Using Colostrum-Derived Exosomes
por: Kandimalla, Raghuram, et al.
Publicado: (2021) -
Exosomes as an Emerging Plasmid Delivery Vehicle for Gene Therapy
por: Wallen, Margaret, et al.
Publicado: (2023) -
Anthocyanidins Inhibit Growth and Chemosensitize Triple-Negative Breast Cancer via the NF-κB Signaling Pathway
por: Aqil, Farrukh, et al.
Publicado: (2021) -
Cumin Prevents 17β-Estradiol-Associated Breast Cancer in ACI Rats
por: Aqil, Farrukh, et al.
Publicado: (2021)